-
1
-
-
79955616361
-
Hepatocellular recurrence after orthotopic liver transplantation: Is combination of alpha-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation
-
Hashemi M, Ghavami S. Hepatocellular recurrence after orthotopic liver transplantation: Is combination of alpha-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation. Hepat Mon.2011;11(3):155-6.
-
(2011)
Hepat Mon
, vol.11
, Issue.3
, pp. 155-156
-
-
Hashemi, M.1
Ghavami, S.2
-
2
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin.2011;61(2):69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, Issue.2
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
3
-
-
77349084899
-
Hepatocellular carcinoma: Epidemiology, surveillance, and diagnosis
-
Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis.2010;30(1):3-16.
-
(2010)
Semin Liver Dis
, vol.30
, Issue.1
, pp. 3-16
-
-
Sherman, M.1
-
4
-
-
40849124295
-
Novel advancements in the management of hepatocellular carcinoma in
-
Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol.2008;48 Suppl 1:S20-37.
-
(2008)
J Hepatol
, vol.48
, Issue.SUPPL. 1
-
-
Llovet, J.M.1
Bruix, J.2
-
5
-
-
84871506377
-
An overview of biomarkers for the diagnosis of hepatocellular carcinoma
-
Abu El Makarem M. An overview of biomarkers for the diagnosis of hepatocellular carcinoma. Hepat Mon.2012;12(10 HCC):e6122.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
El Makarem, M.A.1
-
6
-
-
0027437889
-
Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines
-
Harstrick A, Bokemeyer C, Scharnofkse M, Hapke G, Reile D, Schmoll HJ. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines. Cancer Chemother Pharmacol. 1993;33(1):43-7.
-
(1993)
Cancer Chemother Pharmacol
, vol.33
, Issue.1
, pp. 43-47
-
-
Harstrick, A.1
Bokemeyer, C.2
Scharnofkse, M.3
Hapke, G.4
Reile, D.5
Schmoll, H.J.6
-
7
-
-
0035186082
-
Lobaplatin: A new antitumour platinum drug
-
McKeage MJ. Lobaplatin: a new antitumour platinum drug. Expert Opin Investig Drugs.2001;10(1):119-28.
-
(2001)
Expert Opin Investig Drugs
, vol.10
, Issue.1
, pp. 119-128
-
-
McKeage, M.J.1
-
8
-
-
0030865381
-
Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC)
-
Sternberg CN, de Mulder P, Fossa S, Kaye S, Roberts T, Pawinsky A, et al. Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC). Ann Oncol.1997;8(7):695-6.
-
(1997)
Ann Oncol
, vol.8
, Issue.7
, pp. 695-696
-
-
Sternberg, C.N.1
de Mulder, P.2
Fossa, S.3
Kaye, S.4
Roberts, T.5
Pawinsky, A.6
-
9
-
-
79959675371
-
Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro
-
Dai HY, Liu L, Qin SK, He XM, Li SY. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro. Biomed Pharmacother.2011;65(3):137-41.
-
(2011)
Biomed Pharmacother
, vol.65
, Issue.3
, pp. 137-141
-
-
Dai, H.Y.1
Liu, L.2
Qin, S.K.3
He, X.M.4
Li, S.Y.5
-
10
-
-
0027439637
-
A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion
-
Gietema JA, Guchelaar HJ, de Vries EG, Aulenbacher P, Sleijfer DT, Mulder NH. A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion. Anticancer Drugs.1993;4(1):51-5.
-
(1993)
Anticancer Drugs
, vol.4
, Issue.1
, pp. 51-55
-
-
Gietema, J.A.1
Guchelaar, H.J.2
de Vries, E.G.3
Aulenbacher, P.4
Sleijfer, D.T.5
Mulder, N.H.6
-
11
-
-
84862814414
-
Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE
-
Wang Z, Tang X, Zhang Y, Qi R, Li Z, Zhang K, et al. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE. Biomed Pharmacother. 2012;66(3):161-6.
-
(2012)
Biomed Pharmacother
, vol.66
, Issue.3
, pp. 161-166
-
-
Wang, Z.1
Tang, X.2
Zhang, Y.3
Qi, R.4
Li, Z.5
Zhang, K.6
-
12
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin.2005;55(2):74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
13
-
-
79955898445
-
Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection
-
Yamashita T, Honda M, Kaneko S. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection. J Gastroenterol Hepatol.2011;26(6):960-4.
-
(2011)
J Gastroenterol Hepatol
, vol.26
, Issue.6
, pp. 960-964
-
-
Yamashita, T.1
Honda, M.2
Kaneko, S.3
-
14
-
-
0343130530
-
Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection
-
Rodriguez-Mendez ML, Gonzalez-Quintela A, Aguilera A, Barrio E. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol. 2000;95(5):1316-22.
-
(2000)
Am J Gastroenterol
, vol.95
, Issue.5
, pp. 1316-1322
-
-
Rodriguez-Mendez, M.L.1
Gonzalez-Quintela, A.2
Aguilera, A.3
Barrio, E.4
-
15
-
-
30144437514
-
Epidemiology of viral hepatitis and HIV co-infection
-
Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol.2006;44(1 Suppl):S6-9.
-
(2006)
J Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Alter, M.J.1
-
16
-
-
20244373332
-
Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
-
Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS.2005;19(6):593-601.
-
(2005)
AIDS
, vol.19
, Issue.6
, pp. 593-601
-
-
Konopnicki, D.1
Mocroft, A.2
de Wit, S.3
Antunes, F.4
Ledergerber, B.5
Katlama, C.6
-
17
-
-
84860334991
-
HIV and viral hepatitis coinfections: Advances and challenges
-
Lacombe K, Rockstroh J. HIV and viral hepatitis coinfections: advances and challenges. Gut.2012;61 Suppl 1:i47-58.
-
(2012)
Gut
, vol.61
, Issue.SUPPL. 1
-
-
Lacombe, K.1
Rockstroh, J.2
-
18
-
-
84874233501
-
Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide
-
Zidan A, Scheuerlein H, Schule S, Settmacher U, Rauchfuss F. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon.2012;12(10 HCC):e6894.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Zidan, A.1
Scheuerlein, H.2
Schule, S.3
Settmacher, U.4
Rauchfuss, F.5
-
19
-
-
84871491305
-
Hepatitis B-and hepatitis C-related hepatocellular carcinomas in the United States: Similarities and differences
-
Ng J, Wu J. Hepatitis B-and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences. Hepat Mon.2012;12(10 HCC):e7635.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Ng, J.1
Wu, J.2
-
20
-
-
85044694063
-
Hepatitis B virus / human immunodeficiency virus coinfection and its hepatocarcinogenic potential in sub-saharan black africans
-
Kew MC. Hepatitis B virus / human immunodeficiency virus coinfection and its hepatocarcinogenic potential in sub-saharan black africans. Hepat Mon.2012;12(10 HCC):e7876.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Kew, M.C.1
-
22
-
-
84871482978
-
Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation
-
Du Y, Su T, Ding Y, Cao G. Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation. Hepat Mon.2012;12(10 HCC):e6031.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Du, Y.1
Su, T.2
Ding, Y.3
Cao, G.4
-
23
-
-
29144523100
-
High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran
-
Hashemi M, Alavian SM, Ghavami S, de Serres FJ, Salehi M, Doroudi T, et al. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res.2005;33(4):292-7.
-
(2005)
Hepatol Res
, vol.33
, Issue.4
, pp. 292-297
-
-
Hashemi, M.1
Alavian, S.M.2
Ghavami, S.3
de Serres, F.J.4
Salehi, M.5
Doroudi, T.6
-
24
-
-
33845395329
-
Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus
-
Hashemi M, Naderi M, Rashidi H, Ghavami S. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus. Diabetes Res Clin Pract.2007;75(2):246-8.
-
(2007)
Diabetes Res Clin Pract
, vol.75
, Issue.2
, pp. 246-248
-
-
Hashemi, M.1
Naderi, M.2
Rashidi, H.3
Ghavami, S.4
-
25
-
-
0036926944
-
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
-
Lee P, Gildea TR, Stoller JK. Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleve Clin J Med.2002;69(12):928-9.
-
(2002)
Cleve Clin J Med
, vol.69
, Issue.12
, pp. 928-929
-
-
Lee, P.1
Gildea, T.R.2
Stoller, J.K.3
-
26
-
-
0242525259
-
Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/ New Zealand: Australia, Canada, New Zealand and the United States of America
-
de Serres FJ, Blanco I, Fernandez-Bustillo E. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/ New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet.2003;64(5):382-97.
-
(2003)
Clin Genet
, vol.64
, Issue.5
, pp. 382-397
-
-
de Serres, F.J.1
Blanco, I.2
Fernandez-Bustillo, E.3
-
27
-
-
0042632675
-
Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain
-
de Serres FJ, Blanco I, Fernandez-Bustillo E. Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain. Clin Genet.2003;63(6):490-509.
-
(2003)
Clin Genet
, vol.63
, Issue.6
, pp. 490-509
-
-
de Serres, F.J.1
Blanco, I.2
Fernandez-Bustillo, E.3
-
28
-
-
84871476851
-
Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma
-
Topic A, Ljujic M, Radojkovic D. Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma. Hepat Mon.2012;12(10 HCC):e7635.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Topic, A.1
Ljujic, M.2
Radojkovic, D.3
-
29
-
-
85141832338
-
Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method
-
Blanco I, de Serres FJ, Carcaba V, Lara B, Fernandez-Bustillo E. Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method. Hepat Mon.2012;12(10 HCC):e7434.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Blanco, I.1
de Serres, F.J.2
Carcaba, V.3
Lara, B.4
Fernandez-Bustillo, E.5
-
30
-
-
71749091786
-
S100A8/A9: A Janus-faced molecule in cancer therapy and tumorgenesis
-
Ghavami S, Chitayat S, Hashemi M, Eshraghi M, Chazin WJ, Halayko AJ, et al. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol.2009;625(1-3):73-83.
-
(2009)
Eur J Pharmacol
, vol.625
, Issue.1-3
, pp. 73-83
-
-
Ghavami, S.1
Chitayat, S.2
Hashemi, M.3
Eshraghi, M.4
Chazin, W.J.5
Halayko, A.J.6
-
31
-
-
70449085204
-
S100A8/A9: A mediator of severe asthma pathogenesis and morbidity?
-
Halayko AJ, Ghavami S. S100A8/A9: a mediator of severe asthma pathogenesis and morbidity? Can J Physiol Pharmacol. 2009;87(10):743-55.
-
(2009)
Can J Physiol Pharmacol
, vol.87
, Issue.10
, pp. 743-755
-
-
Halayko, A.J.1
Ghavami, S.2
-
32
-
-
77949270765
-
S100A8/A9 induces autophagy and apoptosis via ROSmediated cross-talk between mitochondria and lysosomes that involves BNIP3
-
Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ, et al. S100A8/A9 induces autophagy and apoptosis via ROSmediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res.2010;20(3):314-31.
-
(2010)
Cell Res
, vol.20
, Issue.3
, pp. 314-331
-
-
Ghavami, S.1
Eshragi, M.2
Ande, S.R.3
Chazin, W.J.4
Klonisch, T.5
Halayko, A.J.6
-
33
-
-
38349040141
-
S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2
-
Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, et al. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta.2008;1783(2):297-311.
-
(2008)
Biochim Biophys Acta
, vol.1783
, Issue.2
, pp. 297-311
-
-
Ghavami, S.1
Kerkhoff, C.2
Chazin, W.J.3
Kadkhoda, K.4
Xiao, W.5
Zuse, A.6
-
34
-
-
53349125963
-
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
-
Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol. 2008;181(7):4666-75.
-
(2008)
J Immunol
, vol.181
, Issue.7
, pp. 4666-4675
-
-
Sinha, P.1
Okoro, C.2
Foell, D.3
Freeze, H.H.4
Ostrand-Rosenberg, S.5
Srikrishna, G.6
-
35
-
-
84871513309
-
S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma
-
Maletzki C, Bodammer P, Breitruck A, Kerkhoff C. S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma. Hepat Mon.2012;12(10 HCC):e7240.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Maletzki, C.1
Bodammer, P.2
Breitruck, A.3
Kerkhoff, C.4
-
36
-
-
79961098029
-
Occupational hepatic disorders in Korea
-
Kim HR, Kim TW. Occupational hepatic disorders in Korea. J Korean Med Sci.2010;25(Suppl):S36-40.
-
(2010)
J Korean Med Sci
, vol.25
, Issue.SUPPL.
-
-
Kim, H.R.1
Kim, T.W.2
-
37
-
-
34047210411
-
TP53 mutations and hepatocellular carcinoma: Insights into the etiology and pathogenesis of liver cancer
-
Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene.2007;26(15):2166-76.
-
(2007)
Oncogene
, vol.26
, Issue.15
, pp. 2166-2176
-
-
Hussain, S.P.1
Schwank, J.2
Staib, F.3
Wang, X.W.4
Harris, C.C.5
-
38
-
-
84875739601
-
Risk of hepatocellular carcinoma in workers exposed to chemicals
-
Uccello M, Malaguarnera G, Corriere T, Biondi A, Basile F, Malaguarnera M. Risk of hepatocellular carcinoma in workers exposed to chemicals. Hepat Mon.2012;12(10 HCC):e5943.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Uccello, M.1
Malaguarnera, G.2
Corriere, T.3
Biondi, A.4
Basile, F.5
Malaguarnera, M.6
-
39
-
-
0014169657
-
Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat
-
Wogan GN, Newberne PM. Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res.1967;27(12):2370-6.
-
(1967)
Cancer Res
, vol.27
, Issue.12
, pp. 2370-2376
-
-
Wogan, G.N.1
Newberne, P.M.2
-
40
-
-
84871493022
-
The role of aflatoxins in hepatocellular carcinoma
-
Wu HC, Santella R. The role of aflatoxins in hepatocellular carcinoma. Hepat Mon.2012;12(10 HCC):e7238.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Wu, H.C.1
Santella, R.2
-
41
-
-
33751160048
-
Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)
-
Tazuma S. Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol.2006;20(6):1075-83.
-
(2006)
Best Pract Res Clin Gastroenterol
, vol.20
, Issue.6
, pp. 1075-1083
-
-
Tazuma, S.1
-
42
-
-
77956049820
-
Pathology of combined hepatocellular-cholangiocarcinoma
-
Yeh MM. Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol.2010;25(9):1485-92.
-
(2010)
J Gastroenterol Hepatol
, vol.25
, Issue.9
, pp. 1485-1492
-
-
Yeh, M.M.1
-
43
-
-
84871499128
-
Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: A case report
-
Al Hamoudi W, Khalaf H, Allam N, Al Sebayel M. Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report. Hepat Mon.2012;12(10 HCC):e5871.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Al Hamoudi, W.1
Khalaf, H.2
Allam, N.3
Al Sebayel, M.4
-
44
-
-
34247602670
-
Survival and apoptosis: A dysregulated balance in liver cancer
-
Fabregat I, Roncero C, Fernandez M. Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int.2007;27(2):155-62.
-
(2007)
Liver Int
, vol.27
, Issue.2
, pp. 155-162
-
-
Fabregat, I.1
Roncero, C.2
Fernandez, M.3
-
45
-
-
84871493808
-
The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma
-
Bassullu N, Turkmen I, Dayangac M, Yagiz Korkmaz P, Yasar R, Akyildiz M, et al. The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma. Hepat Mon.2012;12(10 HCC):e7492.
-
(2012)
Hepat Mon
, vol.12
, Issue.10 HCC
-
-
Bassullu, N.1
Turkmen, I.2
Dayangac, M.3
Yagiz, K.P.4
Yasar, R.5
Akyildiz, M.6
-
46
-
-
78650795200
-
Recent advances of radiofrequency ablation for early hepatocellular carcinoma
-
Izumi N. Recent advances of radiofrequency ablation for early hepatocellular carcinoma. J Gastroenterol Hepatol.2011;26 Suppl 1:115-22.
-
(2011)
J Gastroenterol Hepatol
, vol.26
, Issue.SUPPL. 1
, pp. 115-122
-
-
Izumi, N.1
|